Perbedaan Morenzo Abadi Perkasa Tbk. dan UBC Medical Indonesia Tbk.: Morenzo Abadi Perkasa Tbk. diperdagangkan di Rp69 (kapitalisasi pasar 149,22 M, volume 24 jam 2,58 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,18 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 3,9× kapitalisasi pasar Morenzo Abadi Perkasa Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,18 jt vs 2,58 jt). Mana yang lebih baik tergantung tujuan investasimu.
| ENZO | LABS | |
|---|---|---|
Kapitalisasi Pasar | 149,22 M | 576,7 M |
Volume | 2,58 jt | 3,18 jt |
Lot | 25,75 rb | 31,78 rb |
Perputaran | 175,31 jt | 477,9 jt |
Harga Rata-rata | 68,07 | 150,39 |
Nilai Transaksi | 175,31 jt | 477,9 jt |
Harga Ekuilibrium Indikatif | 69 | 147 |
Volume Ekuilibrium Indikatif | 66 rb | 311 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Selengkapnya di halaman ENZO →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →